Chester County News and Community Website
EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) publicized its Q1 2024 financial results, revealing a 3.0% sales slump compared to last year. Both net sales, totaling $695.4 million, …
West Pharmaceutical Services Posts Q1 2024 Financial Results, Updates Full-Year Guidance Read More
EXTON, PA — Against a challenging backdrop where many financial institutions are retreating from aggressive lending, First Resource Bancorp, Inc. (OTCQX: FRSB), the parent company of First Resource Bank, has …
First Resource Bancorp Propels Forward Amid Market Challenges: Q1 2024 Results Make a Statement Read More
WEST CHESTER, PA — Centinel Spine®, LLC, a pioneering company in the spine industry headquartered in West Chester, Pennsylvania, recently reported its most impressive financial performance to date. The firm …
Centinel Spine Surges to Record Revenue in First Quarter 2024, Leads Spine Industry Growth Read More
MALVERN, PA — Meridian Corporation (Nasdaq: MRBK) has announced its robust financial report for the first quarter of 2024. The banking company also declared a quarterly dividend of $0.125 per …
Meridian Corporation Continues its Momentum, Reflects Progress with First Quarter 2024 Earnings Read More
MALVERN, PA — CubeSmart (NYSE: CUBE) has unveiled its operating results for the first quarter ended March 31, 2024. The Pennsylvania-based self-storage company reported a decrease in same-store net operating …
CubeSmart Unveils Q1 2024 Performance, Anticipates Robust Summer Rental Season Read More
MALVERN, PA — Endo, Inc., a newly established entity, recently unveiled plans to secure new senior secured credit facilities totaling $1.65 billion. The ambitious financial package is comprised of a …
Endo Inc. Announces Major Financing Move with $1.65 Billion in New Credit Facilities Amid Restructuring Read More
MALVERN, PA — Ocugen Inc. (NASDAQ: OCGN released its general business update on Tuesday, revealing promising strides in the pursuit of transformative treatments for blindness diseases. The Pennsylvania-based company’s dedication …
Ocugen Inc. Embarks on A Game-Changing Era With Revolutionary Gene Therapy Initiatives Read More
MALVERN, PA — In a recent financial report for 2023, Annovis Bio, Inc. (NYSE: ANVS) proclaimed progress in the battle against neurodegenerative diseases; however, the path to potential breakthroughs has …
Annovis Bio Makes Strides in Neurodegenerative Disease Treatment: 2023 Q4 Results Below Projections, Progress Seen in Clinical Trials Read More
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN), a leading pharmaceutical company, has recently unveiled its financial outcomes for the closing quarter of 2023, amidst a pivotal shift in their corporate …
Trevena Ramps Up Efforts on TRV045, Turns Attention Away from OLINVYK Amid Challenging Hospital Environment Read More
BERWYN, PA — Recent developments have been flourishing for Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX). The Pennsylvania-based pharmaceutical innovator recently unveiled its financial records for 2023 and shared a series of …
Virpax Pharmaceuticals Set for Transformative Year with High Hopes for Non-Addictive Pain Management Solutions Read More